Trending Now
Business
General Electric: Are Bulls Prepared For A Dilutive Event?
Last week General Electric (GE) filed a shelf registration that will allow the company to offer senior or subordinated debt securities, preferred stock, common...
Indian Farmers Kiki Challenge Goes Viral
Drake has practically bodied any rapper who dared challenge him. He recently got his comeuppance when he took the bait on a Pusha-T sneak...
Lifestyle today
Entertainment
Shire Schooled Me On Drugs Fueling The Dry-Eye Donnybrook
Allergan's (AGN) recent ploy to sell Restasis patents to the St. Regis Mohawk Tribe was perplexing to many. It also brought attention to Allergan's...
Wanda Smith’s Husband Brandishes Gun At Katt Williams For That Heat
Katt Williams' interview with Frank And Wanda In The Morning is about to break the Internet. He was at the V103 in Atlanta last...
Washington AG Bob Ferguson Tweaking So Hard, BMF’s Lamar Is Taking Pictures
President Trump threw down the gauntlet in 2017, promising to bring opioid manufacturers to justice for their role in the opioid epidemic....
Patent Losses Could Sink Allergan
Allergan (AGN) reports Q4 earnings Tuesday. Investors expect revenue of $4.28 billion and eps of $4.74. The revenue estimate implies 6% growth sequentially. Investors...
Nike: North America, Management Departures In Focus
Nike (NKE) reports quarterly earnings after-hours today. Analysts expect revenue of $8.85 billion and eps of $0.53. The revenue estimate implies 4% growth sequentially....
The Fed Hikes Rates, Signals Two More To Come
Fed Chairman Jerome Powell attended the Federal Open Market Committee meeting Wednesday. As expected he hiked interest rates by a quarter-point and intimated at...
Video: Experts Parse Through Endo, Xiaflex And Cellulite
On February 11th beauty experts discussed Endo International, Xiaflex and Cellulite. The discussion was led by Ralph Baker of Shocking The Street and Torian...
Will Generic Copaxone Trigger Teva’s Insolvency?
I previously wondered who would downgrade Teva (TEVA) first? Moody's or S&P? Monday Fitch beat them to it, downgrading the generics giant to junk...
























































































































